Skip to main content

Table 2 Point abstinence rates

From: Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients

 

Week 12

Week 26

Smoking

Abstinent

Total

Smoking

Abstinent

Total

NRTa

27 (71.1%)

11 (28.9%)

38 (52.8%)

25 (69.4%)

11 (30.6%)

36 (53.7%)

Varenicline

16 (55.2%)

13 (44.8%)

29 (40.3%)

18 (66.7%)

9 (33.3%)

27 (40.3%)

NMb

2 (40%)

3 (60%)

5 (6.9%)

2 (50%)

2 (50%)

4 (6%)

Total

45 (62.5%)

27 (37.5%)

72 (100%)

45 (67.2%)

22 (32.8%)

67 (100%)

  1. Abstinence rate at week 12 and 26
  2. aNRT nicotine replacement therapy, bNM no medication group
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us